Prevalence of Risk Factors for Alzheimer, Related Dementias Identified

FRIDAY, May 20, 2022 (HealthDay News) -- The prevalence of risk factors for Alzheimer disease and related dementias varies and is highest for high blood pressure and not meeting aerobic physical activity guidelines, according to research published in the May 20 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
John D. Omura, M.D., from the CDC in Atlanta, and colleagues analyzed data from the cognitive decline module that was administered to adults aged 45 years and older in 31 states and the District of Columbia in the 2019 Behavioral Risk Factor Surveillance System survey to examine the status of eight potentially modifiable risk factors.
The researchers found that among the risk factors, the prevalence was highest for high blood pressure and not meeting the aerobic physical activity guideline (49.9 and 49.7 percent, respectively), followed by obesity (35.3 percent), and it was lowest for hearing loss and binge drinking (10.5 and 10.3 percent, respectively); prevalence varied by selected demographic characteristics. The likelihood of reporting four or more risk factors was increased for adults with subjective cognitive decline (SCD) versus those without SCD (34.3 versus 13.1 percent). The prevalence of SCD was 11.3 percent overall and increased from 3.9 to 25.0 percent among adults with no risk factors and with four or more risk factors, respectively.
"The findings in this report highlight opportunities to accelerate action, particularly among specific populations at high risk," the authors write. "Public health professionals can implement policy, systems, and environmental strategies to address modifiable risk factors at the population level."
Related Posts
Global Rate of Stroke Cases, Deaths Still Too High
THURSDAY, Dec. 16, 2021 (HealthDay News) -- While strokes and related deaths...
GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
FRIDAY, Oct. 6, 2023 (HealthDay News) -- Use of glucagon-like peptide 1 (GLP-1)...
¿Piensa que su trabajo es ‘socialmente inútil’? No es el único
VIERNES, 4 de agosto de 2023 (HealthDay News) -- ¿Alguna vez ha pensado que su...
Questions Remain About Safety of Aspirin Cessation in Older Adults
MONDAY, March 14, 2022 (HealthDay News) -- A subgroup analysis of the ASPREE...